BR

Balakishan Rao Jupelly

Active Director Director DIN 11482066
DIN 11482066 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Balakishan Rao Jupelly

Data last updated:

Balakishan Rao Jupelly is a Director at Eirian Lifesciences Private Limited (since 2026). The company operates in Pharma.

DIN 11482066
Primary Designation Director
Industry Pharma
First Appointment 13 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eirian Lifesciences Private Limited U21002TS2026PTC209666
Director13 Jan 20262026Active

Board colleagues of Balakishan Rao Jupelly

NameDINCompanyDesignation
Malathi Jupelly11482067Eirian Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eirian Lifesciences Private Limited
Premium access

Shareholding and investment profile for Balakishan Rao Jupelly

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balakishan Rao Jupelly

Balakishan Rao Jupelly currently holds 1 directorship: Eirian Lifesciences Private Limited (Director, since 13 Jan 2026).

Balakishan Rao Jupelly was first appointed on 13 Jan 2026 as Director at Eirian Lifesciences Private Limited.

The current boards of Balakishan Rao Jupelly's companies include Malathi Jupelly (Eirian Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available